Lantheus Holdings (LNTH) Invested Capital (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Invested Capital of $803000.0 for Q1 2026, up 7.5% year-over-year from $747000.0 in Q1 2025, and up 8.81% quarter-over-quarter from $738000.0 in Q4 2025.
Lantheus Holdings (LNTH) Invested Capital (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Invested Capital for 13 consecutive years, with $803000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital rose 7.5% year-over-year to $803000.0; the TTM figure through Mar 2026 stood at $3.2 million (down 99.43% YoY), while the FY2025 annual figure was $738000.0, down 24.23% from the prior year.
- Invested Capital improved to $803000.0 in Q1 2026 per LNTH's latest filing, from $738000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $564.7 million in Q3 2024 and bottomed at $384000.0 in Q2 2023.
- Historically, Invested Capital has averaged $42.1 million across 5 years, with a median of $823000.0 in 2023.
- Annual changes were most pronounced in 2024 — Invested Capital jumped 80229.02% — and 2025, when it sank 99.85%.
- Lantheus Holdings' Invested Capital stood at $99.7 million in 2022, then plunged by 99.17% to $823000.0 in 2023, then rose by 18.35% to $974000.0 in 2024, then slipped by 24.23% to $738000.0 in 2025, then climbed by 8.81% to $803000.0 in 2026.
- Business Quant data shows LNTH's Invested Capital at $803000.0 in Q1 2026, $738000.0 in Q4 2025, and $871000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 630.00 Mn |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 697,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 697,000.00 |
| Mar 31, 2026 | 803,000.00 |
| Dec 31, 2025 | 738,000.00 |
| Sep 30, 2025 | 871,000.00 |
| Jun 30, 2025 | 796,000.00 |
| Mar 31, 2025 | 747,000.00 |
| Dec 31, 2024 | 974,000.00 |
| Sep 30, 2024 | 564.71 Mn |
| Jun 30, 2024 | 868,000.00 |
| Mar 31, 2024 | 734,000.00 |
| Dec 31, 2023 | 823,000.00 |
| Sep 30, 2023 | 703,000.00 |
| Jun 30, 2023 | 384,000.00 |
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 99.70 Mn |
| Sep 30, 2022 | 15.37 Mn |
| Jun 30, 2022 | 14.07 Mn |
| Mar 31, 2022 | 12.88 Mn |
| Dec 31, 2021 | 11.64 Mn |
| Sep 30, 2021 | 10.36 Mn |